Peter Doyle | CEO and Co-Founder
biosimulytics

Peter is the CEO and one of the Co-Founders of Biosimulytics, a spin-out company from University College Dublin in Ireland developing a predictive software platform for improved drug development using a combination of AI and quantum technologies. Peter is a highly experienced and accomplished co-founder, board member, executive and coach in the tech sector, having played key roles in successful ventures across MedTech, Data Communications, Renewables, Cybersecurity and Semiconductors including an IPO on the NASDAQ with a peak valuation of $13BN. Peter is passionate about innovation and the commercialisation of scientific breakthroughs which can make the world a better place and he continues to also provide business advisory and coaching supports to other entrepreneurs, start-ups and scale-ups through his association with the Vrije Universiteit Brussel (VUB) on major EU-funded innovation projects in the photonics domain. Peter is a graduate in International Commerce and Marketing from University College Dublin and the UCD Smurfit Business School in Ireland.